Literature DB >> 10423294

Transmitochondrial differences and varying levels of heteroplasmy in nuclear transfer cloned cattle.

S Hiendleder1, S M Schmutz, G Erhardt, R D Green, Y Plante.   

Abstract

To assess the extent of cytoplasmic genetic variability in cloned cattle produced by nuclear transplantation procedures, we investigated 29 individuals of seven male cattle clones (sizes 2-6) from two different commercial sources. Restriction enzyme and direct sequence analysis of mitochondrial DNA (mtDNA) detected a total of 12 different haplotypes. Transmitochondrial individuals (i.e., animals which share identical nuclei but have different mitochondrial DNA) were detected in all but one of the clones, demonstrating that mtDNA variation among cloned cattle is a very common phenomenon which prevents true genetic identity. The analyses also showed that the cytoplasmic genetic status of some investigated individuals and clones is further complicated by heteroplasmy (more than one mtDNA type in an individual). The relative proportions of different mtDNA-types in two animals with mild heteroplasmy were estimated at 2:98% and 4:96% in DNA samples derived from blood. This is in agreement with values expected from karyoplast-cytoplast volume ratios. In contrast, the mtDNA haplotype proportions observed in six other heteroplasmic animals of two different clones ranged from 21:79% to 57:43%, reflecting a marked increase in donor blastomere mtDNA contributions. These results suggest that mtDNA type of donor embryos and recipient oocytes used in nuclear transfer cattle cloning should be controlled to obtain true clones with identical nuclear and cytoplasmic genomes. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423294     DOI: 10.1002/(SICI)1098-2795(199909)54:1<24::AID-MRD4>3.0.CO;2-S

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  15 in total

Review 1.  Mitochondria as therapeutic targets for cancer stem cells.

Authors:  In Sung Song; Jeong Yu Jeong; Seung Hun Jeong; Hyoung Kyu Kim; Kyung Soo Ko; Byoung Doo Rhee; Nari Kim; Jin Han
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

2.  Aberrant nucleo-cytoplasmic cross-talk results in donor cell mtDNA persistence in cloned embryos.

Authors:  Rhiannon E Lloyd; Joon-Hee Lee; Ramiro Alberio; Emma J Bowles; João Ramalho-Santos; Keith H S Campbell; Justin C St John
Journal:  Genetics       Date:  2006-02-01       Impact factor: 4.562

3.  Complete replacement of the mitochondrial genotype in a Bos indicus calf reconstructed by nuclear transfer to a Bos taurus oocyte.

Authors:  F V Meirelles; V Bordignon; Y Watanabe; M Watanabe; A Dayan; R B Lôbo; J M Garcia; L C Smith
Journal:  Genetics       Date:  2001-05       Impact factor: 4.562

4.  Paternal mitochondrial DNA transmission during nonhuman primate nuclear transfer.

Authors:  Justin C St John; Gerald Schatten
Journal:  Genetics       Date:  2004-06       Impact factor: 4.562

5.  Coexistence of Bos taurus and B. indicus mitochondrial DNAs in nuclear transfer-derived somatic cattle clones.

Authors:  Ralf Steinborn; Pamela Schinogl; David N Wells; Andreas Bergthaler; Mathias Müller; Gottfried Brem
Journal:  Genetics       Date:  2002-10       Impact factor: 4.562

6.  Contrasting effects of in vitro fertilization and nuclear transfer on the expression of mtDNA replication factors.

Authors:  Emma J Bowles; Joon-Hee Lee; Ramiro Alberio; Rhiannon E I Lloyd; Dov Stekel; Keith H S Campbell; Justin C St John
Journal:  Genetics       Date:  2007-05-16       Impact factor: 4.562

Review 7.  Interspecies somatic cell nuclear transfer and preliminary data for horse-cow/mouse iSCNT.

Authors:  R Tayfur Tecirlioglu; Jitong Guo; Alan O Trounson
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

8.  Human therapeutic cloning (NTSC): applying research from mammalian reproductive cloning.

Authors:  Andrew J French; Samuel H Wood; Alan O Trounson
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 9.  Mitochondrial peroxiredoxin III is a potential target for cancer therapy.

Authors:  In-Sung Song; Hyoung-Kyu Kim; Seung-Hun Jeong; Sung-Ryul Lee; Nari Kim; Byoung Doo Rhee; Kyung Soo Ko; Jin Han
Journal:  Int J Mol Sci       Date:  2011-10-21       Impact factor: 5.923

10.  Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy.

Authors:  Jason Hipp; Anthony Atala
Journal:  J Exp Clin Assist Reprod       Date:  2004-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.